The purpose of the Clinical PGx Implementation subcommittee is to i) serve as hub to connect oncology PGx practitioners and ii) to allow oncology PGx practitioners to seek and exchange implementation successes and challenges,

Our 1-year goals are to:

1. Introduce the PGRN Onc SIG to the oncology implementers in the pharmacogenomics community

2. Understand the current state of clinical gene/drug pair implementations at oncology sites

3. Create a searchable database of pharmacogenomics practitioners to facilitate the discussion and exchange of oncology PGx implementation experience

Our 5-year goals are to:

1. Publish articles highlighting unique implementation aspects at oncology PGx sites

2. Establish a network of oncology pharmacogenomics practitioners

3. Serve as the main forum for PGx oncology practitioners for implementation data sharing and collaboration (for example, with IGNITE)

Lead: Cyrine Haidar

Leadership Team:

Cyrine Haidar

April Schultz

Amy Pasternak

Ben Kong

Max Smith

Chakradhara Uppugunduri